Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zyversa Therapeutics Inc (ZVSA)

Zyversa Therapeutics Inc (ZVSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zyversa Therapeutics Inc 2200 N. COMMERCE PARKWAY SUITE 208 WESTON FL 33326 USA

www.zyversa.com Employees: 7 P: 754231688

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

ZyVersa Therapeutics Inc. is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop product candidates which address high unmet medical needs in the areas of renal and inflammatory diseases. The company's development pipeline includes phase 2a ready VAR 200 and IC 100. ZyVersa Therapeutics Inc., formerly known as Larkspur Health Acquisition Corp., is based in WESTON, Fla.

Key Statistics

Overview:

Market Capitalization, $K 1,797
Enterprise Value, $K 267
Shares Outstanding, K 7,940
Float, K 7,923
% Float 99.79%
Short Interest, K 198
Short Float 2.49%
Days to Cover 1.00
Short Volume Ratio 0.51
% of Insider Shareholders 0.21%
% of Institutional Shareholders 3.91%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -9,410 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -19,810 K
EBIT, $ -26,220 K
EBITDA, $ -26,210 K

Growth:

1-Year Return -82.59%
3-Year Return -99.97%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.15 on 11/19/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -1.34
EPS Growth vs. Prev Qtr 67.39%
EPS Growth vs. Prev Year 93.83%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 04/26/24

ZVSA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -255.79%
Return-on-Assets % -45.27%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.48
Interest Coverage -33.85
60-Month Beta 0.82
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar